HK1206025A1 - 吡啶並嘧啶類衍生物、其製備方法及其在醫藥上的應用 - Google Patents

吡啶並嘧啶類衍生物、其製備方法及其在醫藥上的應用

Info

Publication number
HK1206025A1
HK1206025A1 HK15106672.5A HK15106672A HK1206025A1 HK 1206025 A1 HK1206025 A1 HK 1206025A1 HK 15106672 A HK15106672 A HK 15106672A HK 1206025 A1 HK1206025 A1 HK 1206025A1
Authority
HK
Hong Kong
Prior art keywords
miazines
derivate
thiophene
preparation
method therefor
Prior art date
Application number
HK15106672.5A
Other languages
English (en)
Inventor
李心
孫飄揚
蘭炯
彭建彪
陳陽
王斌
董慶
Original Assignee
Shanghai Hengrui Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hengrui Pharm Co Ltd filed Critical Shanghai Hengrui Pharm Co Ltd
Publication of HK1206025A1 publication Critical patent/HK1206025A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15106672.5A 2013-05-17 2015-07-13 吡啶並嘧啶類衍生物、其製備方法及其在醫藥上的應用 HK1206025A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310183029 2013-05-17
PCT/CN2014/075387 WO2014183520A1 (zh) 2013-05-17 2014-04-15 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用

Publications (1)

Publication Number Publication Date
HK1206025A1 true HK1206025A1 (zh) 2015-12-31

Family

ID=51897671

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106672.5A HK1206025A1 (zh) 2013-05-17 2015-07-13 吡啶並嘧啶類衍生物、其製備方法及其在醫藥上的應用

Country Status (4)

Country Link
CN (1) CN104470921B (zh)
HK (1) HK1206025A1 (zh)
TW (1) TWI642667B (zh)
WO (1) WO2014183520A1 (zh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294681B (zh) 2014-07-26 2017-07-07 广东东阳光药业有限公司 Cdk类小分子抑制剂的化合物及其用途
CN105622638B (zh) * 2014-10-29 2018-10-02 广州必贝特医药技术有限公司 嘧啶或吡啶并吡啶酮类化合物及其制备方法和应用
AU2016214897B9 (en) * 2015-02-03 2020-06-04 Jiangsu Hengrui Medicine Co., Ltd. Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor
WO2016169422A1 (zh) * 2015-04-22 2016-10-27 江苏恒瑞医药股份有限公司 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法
CN106065016B (zh) * 2015-04-22 2019-03-12 江苏恒瑞医药股份有限公司 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法
CN105130986B (zh) * 2015-09-30 2017-07-18 广州科擎新药开发有限公司 嘧啶或吡啶并吡啶酮类化合物及其应用
US11225492B2 (en) 2015-12-13 2022-01-18 Hangzhou Innogate Pharma Co., Ltd. Heterocycles useful as anti-cancer agents
CN107028899B (zh) * 2016-02-04 2021-07-02 江苏恒瑞医药股份有限公司 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物
WO2017133542A1 (zh) * 2016-02-04 2017-08-10 江苏恒瑞医药股份有限公司 一种含有吡啶并嘧啶类衍生物或其可药用盐的药物组合物
CN107137409A (zh) * 2016-03-01 2017-09-08 江苏恒瑞医药股份有限公司 一种cdk4/6抑制剂与雌激素受体拮抗剂联合在制备治疗乳腺癌的药物中的用途
CN107137408A (zh) * 2016-03-01 2017-09-08 江苏恒瑞医药股份有限公司 一种cdk4/6抑制剂与芳香化酶抑制剂联合在制备治疗乳腺癌的药物中的用途
WO2017161253A1 (en) 2016-03-18 2017-09-21 Tufts Medical Center Compositions and methods for treating and preventing metabolic disorders
CN105777749A (zh) * 2016-04-06 2016-07-20 中国药科大学 吡啶并嘧啶类化合物、其制备方法及其用途
AR110238A1 (es) * 2016-11-28 2019-03-13 Teijin Pharma Ltd Derivado de pirido[3,4-d]pirimidina y su sal farmacéuticamente aceptable
WO2018108167A1 (zh) 2016-12-16 2018-06-21 基石药业 Cdk4/6抑制剂
CN108794452B (zh) 2017-05-05 2021-05-28 上海时莱生物技术有限公司 具有激酶抑制活性的化合物、其制备方法和用途
WO2018233620A1 (zh) * 2017-06-21 2018-12-27 江苏恒瑞医药股份有限公司 SERD与CDK4/6抑制剂、PI3K/mTOR通路抑制剂的用途
CN109384767B (zh) * 2017-08-08 2020-05-05 江苏恒瑞医药股份有限公司 一种吡啶并嘧啶类衍生物的制备方法及其中间体
CN109867667B (zh) * 2017-12-05 2021-06-11 中国药科大学 含有吡啶并嘧啶结构的parp和pi3k双靶点抑制剂
US20210214358A1 (en) 2018-04-24 2021-07-15 Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Cdk4/6 inhibitor and pharmaceutically acceptable salt and polymorph thereof and use thereof
MX2020012540A (es) * 2018-05-23 2021-02-16 Jiangsu Hengrui Medicine Co Uso de inhibidor de cdk4/6 en combinacion con inhibidor del egfr en la preparacion de medicamento para tratar enfermedades tumorales.
CN110680919A (zh) * 2018-07-06 2020-01-14 江苏恒瑞医药股份有限公司 Cdk4/6抑制剂联合免疫治疗在制备治疗肿瘤的药物的用途
CN110840892A (zh) 2018-08-21 2020-02-28 江苏恒瑞医药股份有限公司 酪氨酸激酶抑制剂与cdk4/6抑制剂联合在制备预防或治疗肿瘤疾病的药物中的用途
TW202034925A (zh) * 2018-12-13 2020-10-01 大陸商江蘇恆瑞醫藥股份有限公司 Ｃｄｋ４／６抑制劑聯合免疫治療在製備治療淋巴瘤的藥物中的用途
MX2021009188A (es) 2019-01-30 2021-11-12 Jiangsu Hengrui Medicine Co Uso de composición que contiene inhibidor de quinasa dependiente de ciclina 4/6 en combinación con anastrozol en la preparación de medicamentos para el tratamiento de enfermedades tumorales.
CN113840608B (zh) * 2019-05-30 2023-11-14 江苏恒瑞医药股份有限公司 Cdk4/6抑制剂与vegfr抑制剂联合在制备治疗肿瘤的药物中的用途
WO2020253808A1 (zh) * 2019-06-20 2020-12-24 江苏恒瑞医药股份有限公司 一种药物组合物以及其制备方法
CN110143948B (zh) * 2019-06-21 2021-05-14 上海博悦生物科技有限公司 Cdk4/6抑制剂、其药物组合物、制备方法及应用
TW202114689A (zh) * 2019-08-06 2021-04-16 大陸商江蘇恒瑞醫藥股份有限公司 Cdk4/6抑制劑與多靶點酪胺酸激酶抑制劑聯合在製備治療腫瘤的藥物中的用途
TW202114667A (zh) * 2019-09-11 2021-04-16 大陸商江蘇恒瑞醫藥股份有限公司 Mek抑制劑與cdk4/6抑制劑聯合在製備治療腫瘤的藥物中的用途
TW202114670A (zh) * 2019-09-30 2021-04-16 大陸商江蘇恒瑞醫藥股份有限公司 一種ezh2抑制劑與cdk4/6抑制劑聯合在製備治療腫瘤藥物中的用途
CN110540535B (zh) * 2019-10-23 2020-07-31 上海再启生物技术有限公司 适合放大制备4-(6-氨基吡啶-3-基)取代哌啶的工艺方法
WO2022113003A1 (en) 2020-11-27 2022-06-02 Rhizen Pharmaceuticals Ag Cdk inhibitors
CN112778303A (zh) * 2020-12-31 2021-05-11 武汉九州钰民医药科技有限公司 Cdk4/6激酶抑制剂shr6390的制备方法
WO2022149057A1 (en) 2021-01-05 2022-07-14 Rhizen Pharmaceuticals Ag Cdk inhibitors
WO2023284790A1 (zh) * 2021-07-13 2023-01-19 江苏恒瑞医药股份有限公司 选择性雌激素受体共价拮抗剂与cdk4/6抑制剂联合在制备治疗乳腺癌药物中的用途
CN114456180B (zh) * 2022-02-18 2023-07-25 贵州大学 用于治疗和/或预防恶性肿瘤的化合物及药物制剂和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062236A1 (en) * 2002-01-22 2003-07-31 Warner-Lambert Company Llc 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
RU2009108006A (ru) * 2006-09-08 2010-10-20 Пфайзер Продактс Инк. (Us) Синтез 2-(пиридин-2-иламино)-пиридо[2, 3-d]пиримидин-7-онов
JP2010523677A (ja) * 2007-04-11 2010-07-15 エクセリクシス， インク． 癌の治療のためのＰＩ３Ｋα阻害剤としてのピリド［２，３−Ｄ］ピリミジン−７−オン
EP2300013B1 (en) * 2008-05-21 2017-09-06 Ariad Pharmaceuticals, Inc. Phosphorous derivatives as kinase inhibitors
US20110224221A1 (en) * 2008-10-01 2011-09-15 Sharpless Norman E Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors
US8680099B2 (en) * 2010-06-10 2014-03-25 Afraxis Holdings, Inc. 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
CN103012399B (zh) * 2012-11-22 2015-06-17 中国科学院广州生物医药与健康研究院 7-氧代吡啶并嘧啶类化合物及其药用组合物和应用

Also Published As

Publication number Publication date
CN104470921B (zh) 2017-05-03
TWI642667B (zh) 2018-12-01
CN104470921A (zh) 2015-03-25
WO2014183520A1 (zh) 2014-11-20
TW201444838A (zh) 2014-12-01

Similar Documents

Publication Publication Date Title
HK1206025A1 (zh) 吡啶並嘧啶類衍生物、其製備方法及其在醫藥上的應用
HRP20170888T1 (hr) Spoj tubulisina, metode pripreme i primjena
HK1203317A1 (zh) 可食用組合物及其製備方法和用途
EP2953012A4 (en) ELECTRONIC SKIN, METHOD OF MANUFACTURE AND USE THEREOF
HK1222778A1 (zh) 醫用裝置及使用該醫用裝置的方法
EP2968304A4 (en) 4-PHENYLPIPERIDINES, PREPARATION THEREOF AND USE THEREOF
GB202005995D0 (en) Patient interface and aspects thereof
EP2968303A4 (en) OCTAHYDROCYCLOPENTAPYROLE AND THEIR PREPARATION AND USE
EP3088353A4 (en) BILIRUBINNANOPARTICLES, USE AND MANUFACTURING METHOD THEREFOR
HK1203398A1 (zh) 可食用組合物及其製備方法和用途
HK1225993A1 (zh) 糖胺聚糖的化合物、其製備方法及用途
ZA201601343B (en) Vancomycin derivative, and preparation method and application thereof
HK1218120A1 (zh) 三環苯並氧雜硼化合物、其製備方法與應用
EP2813495A4 (en) 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF
HK1203397A1 (zh) 可食用組合物及其製備方法和用途
HK1206329A1 (zh) 苯酚衍生物及其製備方法和在醫藥上的應用
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
ZA201600015B (en) Anti-fibrogenic compounds, methods and uses thereof
EP3078659A4 (en) 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3006432A4 (en) 2,3-BANDEDIAMIDE EPOXY COMPOUND AND METHOD OF MANUFACTURE AND USE THEREOF
GB201315887D0 (en) Medical applicator
ZA201603990B (en) Taxane compound, and preparation method and use thereof
EP2987794A4 (en) VINBLASTINE DERIVATIVES, PROCESS FOR THEIR SYNTHESIS AND THEIR APPLICATION
EP2980096A4 (en) 2,3,5-trihydroxy-androst-6-one, as well as method of preparation and use thereof
ZA201603682B (en) Taxanes compounds, preparation method therefor, and uses thereof